Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00807209 · ClinicalTrials.gov registry record · Phase 2
Dose Finding Posterolateral Thoracotomy Study
A Phase 2 study, sponsored by Pacira Pharmaceuticals.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT00807209: Clinical Trial Phase 2 study, sponsored by Pacira Pharmaceuticals.
NCT00807209 is a Phase 2 study that was terminated before completion, run by Pacira Pharmaceuticals. The registered enrollment target is 3 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00807209, a Phase 2 study, was terminated before completion, sponsored by Pacira Pharmaceuticals.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
To review safety and effectiveness of two doses compared to current standard of care.
Primary Outcome
The primary outcome metric was to be the amount of rescue epidural fentanyl administered for breakthrough pain during the first 72 hours postoperatively. Patient-controlled analgesia (PCA) fentanyl intake was to be summarized for each treatment group as time to first use of rescue PCA fentanyl, amount of PCA fentanyl administered over 72 hours, and total amount of PCA fentanyl administered through a number of time intervals. However, efficacy analyses were not performed because the study was ter
Interventions
- DRUG Placebo
- DRUG Low Dose SKY0402
- DRUG High Dose SKY0402
- DRUG Fentanyl via PCA
- DRUG Bupivacaine via epidural
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-02 |
| Phase | Phase 2 |
Why NCT00807209 stopped before completion
NCT00807209 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT00807209 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00807209 about?
NCT00807209 is a clinical study titled "Dose Finding Posterolateral Thoracotomy Study". To review safety and effectiveness of two doses compared to current standard of care.
What is the current status of trial NCT00807209?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2008-12. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00807209?
The interventions under investigation include: Placebo (DRUG), Low Dose SKY0402 (DRUG), High Dose SKY0402 (DRUG), Fentanyl via PCA (DRUG), Bupivacaine via epidural (DRUG).
Who is sponsoring clinical trial NCT00807209?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00807209's enrollment target sits among peer trials
3 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia